Document is current
Any future updates will be listed below
-
Authors
Sada, Ken-Ei https://orcid.org/0000-0003-1020-0818
Ohashi, Keiji
Asano, Yosuke
Hayashi, Keigo
Morishita, Michiko
Watanabe, Haruki
Matsumoto, Yoshinori
Fujimoto, Shouichi
Takasaki, Yoshinari
Yamagata, Kunihiro
Banno, Shogo
Dobashi, Hiroaki
Amano, Koichi
Harigai, Masayoshi
Arimura, Yoshihiro
Makino, Hirofumi
,
Usui, Joichi
Atsumi, Tatsuya
Sugihara, Takahiko
Matsuo, Seiichi
Sugiyama, Hitoshi
Ishizu, Akihiro
Fujii, Takao
Okada, Yasunori
Homma, Sakae
Tsuboi, Naotake
Kumagai, Shunichi
Muso, Eri
Murakawa, Yohko
Banno, Shogo
Hasegawa, Hitoshi
Yumura, Wako
Matsubara, Hiroaki
Yoshida, Masaharu
Katsuoka, Kensei
Ogawa, Noriyoshi
Komatsuda, Atsushi
Ito, Satoshi
Kawakami, Atsushi
Nakaya, Izaya
Saito, Takao
Ito, Takafumi
Hirawa, Nobuhito
Yamamura, Masahiro
Nakano, Masaaki
Nitta, Kosaku
Ogura, Makoto
Naniwa, Taio
Ozaki, Shoichi
Hirahashi, Junichi
Hosoya, Tatsuo
Wada, Takashi
Horikoshi, Satoshi
Kawaguchi, Yasushi
Hayashi, Taichi
Watanabe, Tsuyoshi
Inaguma, Daijo
Tsuruya, Kazuhiko
Homma, Noriyuki
Takeuchi, Tsutomu
Nakagawa, Naoki
Takeda, Shinichi
Katafuchi, Ritsuko
Iwano, Masayuki
Kobayashi, Masaki
-
Funding
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (nannti-ippann-004, nannti-ippann-018)
Japan Agency for Medical Research and Development (JP17ek0109104, JP17ek0109121)
Japan Agency for Medical Research and Development (JP18ek0109360)
- License Information
-
More Information
Article History
Received: 9 July 2020
Accepted: 2 October 2020
First Online: 12 October 2020
Ethics approval and consent to participate
: This study was conducted in accordance with the Declaration of Helsinki and the ethical guidelines for epidemiological research in Japan. This study was approved by the Ethics Committee of Okayama University Hospital and Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences (approval number, Ken1904-023). Informed consent and permission to publish their data were obtained from all participants.
: No individual person’s data were presented in any form in this study, and therefore, no consent to publish is required.
: KS received speaker’s fee from Astra Zeneca K.K. KA received speaker’s fee from Chugai Pharmaceutical Co. MH has received unrestricted research grants from AbbVie Japan GK; Ayumi Pharmaceutical Co.; Bristol Myers Squibb Co., Ltd.; Eisai Co., Ltd.; Nippon Kayaku Co., Ltd.; Mitsubishi Tanabe Pharma Co.; and Teijin Pharma Ltd. MH has received speaker’s fee from Boehringer-Ingelheim; Kissei Pharmaceutical Co., Ltd.; Eli Lilly Japan K.K.; and Chugai Pharmaceutical Co., Ltd. MH is a consultant for AbbVie; Boehringer-Ingelheim; Kissei Pharmaceutical Co., Ltd.; and Teijin Pharma. HM is a consultant for AbbVie, Boehringer-Ingelheim, and Teijin.
